Crossmark

FBXO32 suppresses breast cancer tumorigenesis through targeting KLF4 to proteasomal degradation

Published Online: 2017-01-09

Published Print: 2017-06-08

Authors

Zhou, H

Liu, Y

Zhu, R

Ding, F

Wan, Y

Li, Y

Liu, Z
License Information

Text and Data Mining valid from 2017-01-09

Version of Record valid from 2017-01-09
More Information

Article History

Received: 14 April 2016

Revised: 10 November 2016

Accepted: 15 November 2016

First Online: 9 January 2017

Competing interests

: The authors declare no conflict of interest.

Document is current